Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy.

Celestia S. Higano; Lauren C. Harshman; Sabina Dizdarevic; John Logue; Timothy Richardson; Saby George; Danny Song; Igle J. de Jong; Jeffrey Tomaszewski; Fred Saad; Kurt Miller; Jeffrey Meltzer; Per Sandstrom; Bertrand F. Tombal; A. Oliver Sartor

Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy.

Celestia S. Higano
, Lauren C. Harshman
, Sabina Dizdarevic
, John Logue
, Timothy Richardson
, Saby George
, Danny Song
, Igle J. de Jong
, Jeffrey Tomaszewski
, Fred Saad
, Kurt Miller
, Jeffrey Meltzer
, Per Sandstrom
, Bertrand F. Tombal
, A. Oliver Sartor

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	38
Issue number	15
Publication status	Published - 20-May-2020

Handle.net

Persistent link

Cite this

Higano, C. S., Harshman, L. C., Dizdarevic, S., Logue, J., Richardson, T., George, S., Song, D., de Jong, I. J., Tomaszewski, J., Saad, F., Miller, K., Meltzer, J., Sandstrom, P., Tombal, B. F., & Sartor, A. O. (2020). Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy. Journal of Clinical Oncology, 38(15).

@article{89d249c8cd174f9eaf5e7688e58e1b6f,

title = "Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy.",

author = "Higano, \{Celestia S.\} and Harshman, \{Lauren C.\} and Sabina Dizdarevic and John Logue and Timothy Richardson and Saby George and Danny Song and \{de Jong\}, \{Igle J.\} and Jeffrey Tomaszewski and Fred Saad and Kurt Miller and Jeffrey Meltzer and Per Sandstrom and Tombal, \{Bertrand F.\} and Sartor, \{A. Oliver\}",

year = "2020",

month = may,

day = "20",

language = "English",

volume = "38",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "AMER SOC CLINICAL ONCOLOGY",

number = "15",

}

Higano, CS, Harshman, LC, Dizdarevic, S, Logue, J, Richardson, T, George, S, Song, D, de Jong, IJ, Tomaszewski, J, Saad, F, Miller, K, Meltzer, J, Sandstrom, P, Tombal, BF & Sartor, AO 2020, 'Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy.', Journal of Clinical Oncology, vol. 38, no. 15.

Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy. / Higano, Celestia S.; Harshman, Lauren C.; Dizdarevic, Sabina et al.
In: Journal of Clinical Oncology, Vol. 38, No. 15, 20.05.2020.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy.

AU - Higano, Celestia S.

AU - Harshman, Lauren C.

AU - Dizdarevic, Sabina

AU - Logue, John

AU - Richardson, Timothy

AU - George, Saby

AU - Song, Danny

AU - de Jong, Igle J.

AU - Tomaszewski, Jeffrey

AU - Saad, Fred

AU - Miller, Kurt

AU - Meltzer, Jeffrey

AU - Sandstrom, Per

AU - Tombal, Bertrand F.

AU - Sartor, A. Oliver

PY - 2020/5/20

Y1 - 2020/5/20

M3 - Meeting Abstract

SN - 0732-183X

VL - 38

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -